CN Patent

CN112004802A — 作为神经元组胺受体-3拮抗剂的化合物及其用途

Assigned to XWPharma Ltd · Expires 2020-11-27 · 5y expired

What this patent protects

本发明涉及作为H3R拮抗剂的式(A)化合物及其制备和用途，还涉及包含这些化合物的药物组合物及其作为组胺3受体(H3R)功能调节剂的用途。本发明还涉及所述化合物或药物组合物在治疗或预防人中与H3R功能相关的某些障碍和疾病中的用途。

USPTO Abstract

本发明涉及作为H3R拮抗剂的式(A)化合物及其制备和用途，还涉及包含这些化合物的药物组合物及其作为组胺3受体(H3R)功能调节剂的用途。本发明还涉及所述化合物或药物组合物在治疗或预防人中与H3R功能相关的某些障碍和疾病中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN112004802A
Jurisdiction
CN
Classification
—
Expires
2020-11-27
Drug substance claim
No
Drug product claim
No
Assignee
XWPharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.